CLDT Q1 2026 Earnings NarrowerThanExpected Loss Amid Operational Discipline BriaCell Therapeutics Q1 2026 Earnings NarrowerthanExpected EPS Loss Despite No Revenue ACAD Q1 2026 Earnings EPS Misses by 684 Stock Declines ASC Q1 2026 Earnings Strong EPS Beat Amidst Operational Gains MRVI Q1 2026 Earnings EPS Surprises to the Upside Stock Falls Amid Cautious Outlook C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue